CN Patent

CN102643256B — 一种芳基糖苷类化合物及其制备方法和应用

Assigned to Shanghua Kechuang Investment Management Jiangsu Co ltd · Expires 2014-12-24 · 11y expired

What this patent protects

本发明公开了一种如式I或I’所示的芳基糖苷类化合物、其药学上可接受的盐、其光学异构体或其前药，本发明还涉及上述芳基糖苷类化合物的制备方法和应用。本发明的芳基糖苷类化合物对SGLT，特别是SGLT2具有非常好的抑制活性，是一类极具潜力的抗糖尿病药物。

USPTO Abstract

本发明公开了一种如式I或I’所示的芳基糖苷类化合物、其药学上可接受的盐、其光学异构体或其前药，本发明还涉及上述芳基糖苷类化合物的制备方法和应用。本发明的芳基糖苷类化合物对SGLT，特别是SGLT2具有非常好的抑制活性，是一类极具潜力的抗糖尿病药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN102643256B
Jurisdiction
CN
Classification
—
Expires
2014-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Shanghua Kechuang Investment Management Jiangsu Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.